Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2016 Dec 16;291(51):26586. doi: 10.1074/jbc.A116.717736

Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation.

Elodie Weider, Delia Susan-Resiga, Rachid Essalmani, Josée Hamelin, Marie-Claude Asselin, Surendra Nimesh, Yahya Ashraf, Keith L Wycoff, Jianbing Zhang, Annik Prat, Nabil G Seidah
PMCID: PMC5159516  PMID: 27986868

VOLUME 291 (2016) PAGES 16659–16671

PAGE 16665:

The units of the apolipoprotein B levels (apoB) measured in Figs. 7 and 8 were incorrect. The correct units are μg/ml. This error has now been corrected and does not affect the results or conclusions of the work.

graphic file with name zbc0511658920001.jpg

graphic file with name zbc0511658920002.jpg


Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES